We underscore that the level of upregulation of DAM genes and downregulation of homeo genes differs between those we regularly identify in APP transgenic mice and which are associated with amyloid deposition, suggesting that the neurodegenerative process in Kl-deficient mice is different when compared to AD mouse models. This evidence concerns the gene KL and Alzheimer disease.